• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Comparative in-vitro activity of cefoperazone/sulbactam and 11 other agents against multidrug resistant Bacteroides fragilis group species.

作者信息

Goldstein E J, Citron D M

机构信息

R.M. Alden Research Laboratory, Santa Monica-UCLA Medical Center 90404, USA.

出版信息

J Antimicrob Chemother. 1996 Oct;38(4):733-7. doi: 10.1093/jac/38.4.733.

DOI:10.1093/jac/38.4.733
PMID:8937969
Abstract

The activity of cefoperazone/sulbactam was compared with eleven other antimicrobial agents against 91 strains of the Bacteroides fragilis group known to be resistant to clindamycin and/or beta-lactam agents. Sulbactam alone possessed moderate activity against most strains and improved the activity of cefoperazone and ampicillin. Bacteroides distasonis strains were more resistant than other species. There was no correlation between resistance of an isolate to either clindamycin or cefoxitin with resistance to cefoperazone/sulbactam.

摘要

相似文献

1
Comparative in-vitro activity of cefoperazone/sulbactam and 11 other agents against multidrug resistant Bacteroides fragilis group species.
J Antimicrob Chemother. 1996 Oct;38(4):733-7. doi: 10.1093/jac/38.4.733.
2
Inhibitory and bactericidal activity of selected beta-lactam agents alone and in combination with beta-lactamase inhibitors compared with that of cefoxitin and metronidazole against cefoxitin-susceptible and cefoxitin-resistant isolates of the Bacteroides fragilis group.与头孢西丁和甲硝唑相比，所选β-内酰胺类药物单独及与β-内酰胺酶抑制剂联合使用时，对脆弱拟杆菌群中头孢西丁敏感和耐药菌株的抑制及杀菌活性。
Diagn Microbiol Infect Dis. 1992 May-Jun;15(4):321-30. doi: 10.1016/0732-8893(92)90018-o.
3
In vitro activity of cefoperazone/sulbactam and other antimicrobials against anaerobic bacteria.
Diagn Microbiol Infect Dis. 1990 Jan-Feb;13(1):51-5. doi: 10.1016/0732-8893(90)90054-y.
4
Susceptibilities of 394 Bacteroides fragilis, non-B. fragilis group Bacteroides species, and Fusobacterium species to newer antimicrobial agents.394株脆弱拟杆菌、非脆弱拟杆菌属拟杆菌种及梭杆菌属细菌对新型抗菌药物的敏感性
Antimicrob Agents Chemother. 1991 Jun;35(6):1214-8. doi: 10.1128/AAC.35.6.1214.
5
In vitro activity of cefoperazone plus sulbactam compared with that of other antimicrobial agents against anaerobic bacteria.头孢哌酮加舒巴坦与其他抗菌药物对厌氧菌的体外活性比较。
Antimicrob Agents Chemother. 1988 Mar;32(3):403-6. doi: 10.1128/AAC.32.3.403.
6
Comparative susceptibility of the Bacteroides fragilis group species and other anaerobic bacteria to meropenem, imipenem, piperacillin, cefoxitin, ampicillin/sulbactam, clindamycin and metronidazole.脆弱拟杆菌群物种及其他厌氧菌对美罗培南、亚胺培南、哌拉西林、头孢西丁、氨苄西林/舒巴坦、克林霉素和甲硝唑的敏感性比较。
J Antimicrob Chemother. 1993 Mar;31(3):363-72. doi: 10.1093/jac/31.3.363.
7
In-vitro study of the susceptibility of cefoxitin/cefotetan resistant Bacteroides fragilis group strains to various other antimicrobial agents.对头孢西丁/头孢替坦耐药的脆弱拟杆菌群菌株对各种其他抗菌剂敏感性的体外研究。
J Antimicrob Chemother. 1990 Sep;26(3):353-9. doi: 10.1093/jac/26.3.353.
8
Cross-resistance to beta-lactam-beta-lactamase inhibitor combinations and clindamycin among cefoxitin-resistant and cefoxitin-susceptible strains of the Bacteroides fragilis group.脆弱拟杆菌群中对头孢西丁耐药和敏感菌株对β-内酰胺-β-内酰胺酶抑制剂组合及克林霉素的交叉耐药性
Diagn Microbiol Infect Dis. 1993 Oct;17(3):251-6. doi: 10.1016/0732-8893(93)90107-i.
9
Newer beta-lactam agents and the Bacteroides fragilis group.新型β-内酰胺类药物与脆弱拟杆菌群
Pharmacotherapy. 1991;11(2 ( Pt 2)):51S-55S.
10
beta-Lactamase inhibition and in vitro activity of sulbactam and sulbactam/cefoperazone.舒巴坦及舒巴坦/头孢哌酮的β-内酰胺酶抑制作用和体外活性
Clin Infect Dis. 1997 Mar;24(3):494-7. doi: 10.1093/clinids/24.3.494.

引用本文的文献

1
: intriguing aerotolerant gut anaerobe with emerging antimicrobial resistance and pathogenic and probiotic roles in human health.: 一种具有新兴抗微生物耐药性的有趣的耐气肠道厌氧菌，在人类健康中具有致病性和益生菌作用。
Gut Microbes. 2021 Jan-Dec;13(1):1922241. doi: 10.1080/19490976.2021.1922241.